Franchise GP’s Eli Lilly LLY Stock Holding History

Franchise GP’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$920K	–	44
2026 Q1	$920K	Buy	+1,000	New	+$1.01M	0.34%	20

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Franchise GP's LLY Position: Q2 2026 in Review

Franchise GP sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,000 shares — an estimated $920K sold.

Franchise GP first reported a position in LLY in Q1 2026 and held it in 1 quarter. The position peaked at $920K in Q1 2026. 4,092 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Franchise GP reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Franchise GP sold 1,000 Eli Lilly shares in Q2 2026, an estimated $920K.
Franchise GP first reported a position in Eli Lilly in Q1 2026 and held it in 1 quarter.
Franchise GP's Eli Lilly position peaked at $920K in Q1 2026.
4,092 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Franchise GP's 13F filing for Q2 2026, filed 22 Jul 2026.